Overall decrease in the susceptibility of Mycoplasma bovis to antimicrobials over the past 30 years in France.
Mycoplasma (M.) bovis is frequently implicated in respiratory diseases of young cattle worldwide. Today, to combat M. bovis in Europe, only antimicrobial therapy is available, but often fails, leading to important economical losses. The antimicrobial susceptibility of M. bovis is not covered by anti...
Main Authors: | Anne V Gautier-Bouchardon, Séverine Ferré, Dominique Le Grand, Agnès Paoli, Emilie Gay, François Poumarat |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24503775/?tool=EBI |
Similar Items
-
Comparative assessment of two commonly used commercial ELISA tests for the serological diagnosis of contagious agalactia of small ruminants caused by <it>Mycoplasma agalactiae</it>
by: Poumarat François, et al.
Published: (2012-07-01) -
The presence of Mycoplasma bovis in colostrum
by: Linde Gille, et al.
Published: (2020-04-01) -
Genes found essential in other mycoplasmas are dispensable in Mycoplasma bovis.
by: Shukriti Sharma, et al.
Published: (2014-01-01) -
SEROEPIDEMIOLOGICAL INVESTIGATION OF MYCOPLASMA BOVIS IN CALVES
by: Branka Vidić, et al.
Published: (2015-01-01) -
Pathogenesis of Mycoplasma bovis pneumonia in calves
by: Wrigley, Karina Mary
Published: (2013)